Achievement of Target Systolic Blood Pressure for Lowering the Risk of Major Adverse Cardiovascular Events: From the Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial

被引：0
|
作者：
Hartaigh, Briain O.
Szymonifka, Jackie
Okin, Peter M.
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Diabetes Mellitus; Blood pressure; Antihypertensive agents; Cardiovascular disease prevention; Epidemiology;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13850
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Achievement of Target Systolic Blood Pressure for Lowering the Risk of Major Adverse Cardiovascular Events: From the Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial
    Hartaigh, Briain O.
    Szymonifka, Jackie
    Okin, Peter M.
    [J]. CIRCULATION, 2016, 134
  • [2] Achievement of Blood Pressure Target and Risk of Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Metabolic Syndrome
    Lim, Jimin
    Lee, Soojin
    Kwon, Jungheon
    Paek, Jin Hyuk
    Park, Woo Yeong
    Jin, Kyubok
    Han, Seungyeup
    Kim, Dong Ki
    Kim, Yaerim
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 546 - 546
  • [3] EFFECTS OF INTENSIVE BLOOD PRESSURE CONTROL ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES MELLITUS: THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) BLOOD PRESSURE TRIAL
    Grimm, R.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E602 - E602
  • [4] Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial
    Contreras, Gabriel
    Lu, Lingyi
    Tamariz, Leonardo
    Rocco, Michael V.
    Papademetriou, Vasilios
    Kostis, John B.
    Pisoni, Roberto
    Glasser, Stephen P.
    Sweeney, Mary E.
    Basile, Jan
    Gren, Lisa H.
    Zamanian, Sara
    Cushman, William C.
    [J]. JOURNAL OF HYPERTENSION, 2020, 38 (08) : 1567 - 1577
  • [5] Blood pressure and the risk of major adverse cardiovascular events among firefighters
    Noh, Juhwan
    Lee, Chan Joo
    Hyun, Dae-Sung
    Kim, Woojin
    Kim, Mi-Ji
    Park, Ki-Soo
    Koh, Sangbaek
    Chang, Sei-Jin
    Kim, Changsoo
    Park, Sungha
    [J]. JOURNAL OF HYPERTENSION, 2020, 38 (05) : 850 - 857
  • [6] Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events
    Buckley, Leo F.
    Baker, William L.
    Van Tassell, Benjamin W.
    Cohen, Jordana B.
    Alkhezi, Omar
    Bress, Adam P.
    Dixon, Dave L.
    [J]. HYPERTENSION, 2023, 80 (02) : 305 - 313
  • [7] Target blood pressure levels and the risk of major adverse cardiovascular events among patients with hypertension at low cardiovascular disease risk
    Jiao, Tianze
    Platt, Robert W.
    Douros, Antonios
    Filion, Kristian B.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 350 - 350
  • [8] Blood pressure lowering and cardiovascular risk
    Stoner, Lee
    Wu, Brian
    [J]. LANCET, 2014, 384 (9956): : 1746 - 1746
  • [9] Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial
    Soliman, Elsayed Z.
    Byington, Robert P.
    Bigger, J. Thomas
    Evans, Gregory
    Okin, Peter M.
    Goff, David C.
    Chen, Haiying
    [J]. HYPERTENSION, 2015, 66 (06) : 1123 - 1129
  • [10] Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
    Huang, Chenxi
    Dhruva, Sanket S.
    Coppi, Andreas C.
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Nasir, Khurram
    Krumholz, Harlan M.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (11):
12345